Page last updated: 2024-09-03

sr 11237 and am 580

sr 11237 has been researched along with am 580 in 1 studies

*Am 580: a selctive retinoic acid receptor (alpha) agonist; structure given in first source [MeSH]

*Am 580: a selctive retinoic acid receptor (alpha) agonist; structure given in first source [MeSH]

Compound Research Comparison

Studies
(sr 11237)
Trials
(sr 11237)
Recent Studies (post-2010)
(sr 11237)
Studies
(am 580)
Trials
(am 580)
Recent Studies (post-2010) (am 580)
2609102031

Protein Interaction Comparison

ProteinTaxonomysr 11237 (IC50)am 580 (IC50)
Retinoic acid receptor alphaHomo sapiens (human)0.041

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brooks, SC; Kazmer, S; Levin, AA; Yen, A1

Other Studies

1 other study(ies) available for sr 11237 and am 580

ArticleYear
Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs.
    Blood, 1996, Jan-01, Volume: 87, Issue:1

    Topics: Benzoates; Cell Differentiation; Chromans; Cyclohexanes; Fatty Acids, Unsaturated; Flow Cytometry; HL-60 Cells; Humans; Ligands; Neoplasm Proteins; Pentanoic Acids; Phosphorylation; Protein Processing, Post-Translational; Receptors, Retinoic Acid; Retinoblastoma Protein; Retinoid X Receptors; Retinoids; Structure-Activity Relationship; Substrate Specificity; Tetrahydronaphthalenes; Transcription Factors; Tretinoin

1996